> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-128/
- Published: 2017-03-26T12:00:00.000Z
- Updated: 2026-09-14T22:13:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138300

[**Draft Guide on Kidney Transplantation Drugs**](https://www.fdaweb.com/draft-guide-on-kidney-transplantation-drugs/) 03/24/2017  
*Federal Register* notice: FDA announces the availability of a draft guidance on “Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention. 

[**CDRH Seeks Experiential Learning Program Players**](https://www.fdaweb.com/cdrh-seeks-experiential-learning-program-players/) 03/23/2017  
*Federal Register* notice: CDRH announces its 2017 Experiential Learning Program, a training component that is intended to provide Center staff with an opportunity to understand the policies, laboratory practices, patient perspective/input, quality system management, and other challenges industry faces.

[**Conference on Generic Drug Development**](https://www.fdaweb.com/conference-on-generic-drug-development/) 03/22/2017  
*Federal Register* notice: FDA announces a two-day (4/4-5) public conference entitled “FDA CDER Small Business and Industry Assistance (SBIA) Regulatory Education for Industry (REdI) Generic Drugs Forum.”

[**FDA Comments Sought on Custom Device Reporting**](https://www.fdaweb.com/fda-comments-sought-on-custom-device-reporting/) 03/21/2017  
*Federal Register* Notice: FDA seeks comments on an information collection extension for “Annual Reporting for Custom Device Exemption.”

[**FDA Delays for 1 Year Intended Use Final Rule**](https://www.fdaweb.com/fda-delays-for-1-year-intended-use-final-rule/) 03/20/2017  
*Federal Register* Notice: FDA delays until 3/19/2018 the effective date of its final rule on “Clarification of When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices, or Combination Products; Amendments to Regulations Regarding ‘Intended Uses.’”

[**Workshop Transcript on Cell Therapy Workshop**](https://www.fdaweb.com/workshop-transcript-on-cell-therapy-workshop/) 03/20/2017  
*Federal Register* notice: FDA corrects a 12/29/2016 notice about a public workshop entitled “Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products.”

[**Comments Sought on Device ‘Corrections and Removals’ Reporting**](https://www.fdaweb.com/comments-sought-on-device-corrections-and-removals-reporting/) 03/20/2017  
*Federal Register* notice: FDA seeks comments on a information collection extension entitled “Medical Devices; Reports of Corrections and Removals — 21 CFR Part 806.